looks can be deceptive
play

Looks Can Be Deceptive Case presentation 37 y/o man Original - PowerPoint PPT Presentation

Looks Can Be Deceptive Case presentation 37 y/o man Original kidney disease: Polycystic kidney disease, HTN, highly sensitized Live unrelated renal transplant Jan.2018 5 months post transplant: rising serum Cr.


  1. “Looks Can Be Deceptive” Case presentation

  2. • 37 y/o man • Original kidney disease: Polycystic kidney disease, • HTN, highly sensitized • Live unrelated renal transplant Jan.2018 • 5 months post transplant: rising serum Cr. (94—180) • No proteinuria • Urine and serum viral load: Negative (1 month prior to biopsy) • U/S – No obstruction, perfused kidney • Medications: Steroids, Myfortic & prograft : full maintenance doses  ? Acute rejection

  3. Pathologic Finings Summary (30 glomeruli & 1 artery) Glomeruli‐ 0/30 GS, g0, cg0 Tubulointerstitum‐ • t1 + i1 • ATI • No significant IF/TA(ci0,ct0) • No definitive viral cytopathic change Vessels ‐ v0 , cv0 • ptc 0 • C4d negative Differential diagnosis ?

  4. SV40 SV40

  5. p53 p53

  6. Diagnosis Polyomavirus associated nephropathy (BK virus nephropathy)

  7. Post‐biopsy management Downgrade immunosuppresion + IVIG Full response

  8. • Measurement of decoy cells in urinary sediments may predict early BKV infection • Useful for screening and continuous monitoring. • Frequent urinary BK viral load screening for the prevention of BKVN due to its high sensitivity and earlier detection

  9. • PVAN and acute rejection are not easy to distinguish without arteritis / glomerulitis • HLA‐DR, lymphocytic infiltrate, tubulitis in areas lacking BKV suggest concurrent ACR

  10. p53 staining: • detects a higher percentage of BK virus infected cells than SV40 staining alone. • sensitive and specific method when used along with SV40 staining.

  11. Take home message • Morphologic overlap between TCMR and PVAN • High index of suspicion & SV40 can be helpful in borderline changes • Early PVAN may lack viral cytopathic changes Questions to consider: Questions to consider: ‐ ‐ Routine SV40 ? Routine SV40 ? ‐ ‐ Management of grafts with acute TCMR and positive SV40? Management of grafts with acute TCMR and positive SV40? ‐ Urine cytology vs. urine PCR to monitor BKV reactivation ‐ Urine cytology vs. urine PCR to monitor BKV reactivation

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend